Ataxia telangiectasia and secondary diseases

Turk Pediatri Arsivi

Volumn 47, Issue 1, 2012, Pages 40-44

  Patiroǧlu, Türkan ^a   Güngör, Hatice Eke ^a   Baz, Hüseyin ^b   Ünal, Ekrem ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Göksün Public Hospital   (Turkey)

Author keywords

Ataxia telangiectasia; Cancer; Hashimoto's thyroiditis; Immunological disorder; Secondary diseases

Indexed keywords

IMMUNOGLOBULIN A; THYROID HORMONE;

ARTICLE; ATAXIA TELANGIECTASIA; BRONCHIECTASIS; CLINICAL ARTICLE; CONSANGUINITY; DEATH; DISEASE COURSE; GAIT DISORDER; GENETIC COUNSELING; HASHIMOTO DISEASE; HELPER CELL; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; LYMPHOCYTE SUBPOPULATION; PREVALENCE; RETROSPECTIVE STUDY; SIBLING; TOMOGRAPHY;

EID: 84862738641     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: 10.4274/tpa.594     Document Type: Article

References (17)

1. Chun HH, Gatti RA. Ataxia telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004;3: 1187-96.
2. Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of delayed diagnosis of ataxia telangiectasia. Pediatrics 1998;102: 98-100.
3. Lavin MF, Concannon P, Gatti RA. Eighth International Workshop on Ataxia-Telangiectasia (ATW8). Cancer Res 1999;59: 3845-9.
4. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;286: 1749-53.
5. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3: 155-68.
6. Fark AK, Shalev B, Crawford TO, et al. Ocular manifestations of ataxia telangiectasia. Am J Ophthalmol 2002;134: 891-6.
7. Waldmann TA, McIntire KR. Serum alpha-fetoprotein levels in patients with ataxia telangiectasia. Lancet 1972;2: 1112-5.
8. Peterson RDA, Kelly WD, Good RA. Ataxia telangiectasia. Its association with a defective thymus, immunological deficiency disease and malignancy. Lancet 1964;1: 1189-93.
9. Tavani F, Zimmerman RA, Berry GT, Sullivan K, Gatti R, Bingham P. Ataxia telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology 2003;45: 315-9.
10. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K. Ataxia telangiectasia: an interdisciplinary approach to pathogenesis. Medicine 1991;70: 99-117.
11. Azarsiz E, Gulez N, Edeer Karaca N, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: a single-center study. J Clin Immunol 2011;31: 106-11.
12. Ersoy F, Berkel AI, Sanal O, Oktay H. Twenty-year follow-up of 160 patients with ataxi-telangiectasia. Turk J Pediatr 1991;33: 205-15.
13. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxiatelangiectasia. J Pediatr 2004;144: 505-11.
14. Sanal O, Ersoy F, Yel L, et al. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol 1999;19: 326-34.
15. Yeganeh M, Gambineri E, Abolmaali K, et al. Other well-defined immunodeficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo LD (eds). Primary immunodeficiency diseases 1st ed. Berlin: Springer Pres Verlag, 2008: 251-314.
16. Neeleman C, Verhagen M. Pulmonary function tests in patients with ataxia-telangiectasia: obstructive or restrictive lung dysfunction? Ped Pulmonol 2010;45: 1043-4.
17. Bussone G, Mouthon l. Autoimmune manifestations in primary immune deficiencies. Autoimmunity Rev 2009;8: 332-6.